|
Symbol
|
RMA9EV | ABKBTQ | RMADDV | RMAVPV | ACJMTQ | Z0AYWZ | RMAEBV | RMBYGV | RMAIAV | RMAO0V | RMBNFV | Z0B8PZ | QRERCH | RMAJVV | QTHRCH | RMATAV | ADPWTQ | QVMRCH | RMA5LV | Z25BGZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Auto-Callable Multi Defender VONTI | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible |
|
Underlying
|
Douglas Hldg. AG / Galderma Group AG / UNILEVER TMICC BASKET | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / L'Oréal S.A. / LVMH Moet Hennessy Louis Vuitton | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Accelleron Industries AG / Galderma Group AG / Givaudan | Alcon / Galderma Group AG / Novartis AG / Roche PS / Sandoz Group AG | Galderma Group AG / Nestlé S.A. / Novartis AG | Galderma Group AG / Galenica AG / Straumann Hldg. AG | Alcon / Galderma Group AG / Straumann Hldg. AG | Alcon / Galderma Group AG / Roche PS / Sandoz Group AG | Galderma Group AG / Roche PS / Sanofi S.A. | Alcon / Bachem Hldg. AG / Galderma Group AG | Galderma Group AG / Roche PS / Sandoz Group AG | Galderma Group AG / Partners Group Hldg. AG / Swiss Life Hldg. N | Galderma Group AG / Nestlé S.A. / Novartis AG / Roche PS / Straumann Hldg. AG | Adecco Group AG / Galderma Group AG / UBS Group AG | Alcon / Galderma Group AG / Lonza Group N | Galderma Group AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Alcon / Galderma Group AG / Novartis AG / Roche PS / Straumann Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
28.09.2026 | 12.11.2026 | 05.01.2027 | 22.03.2027 | 17.09.2026 | 08.07.2027 | 25.05.2027 | 10.12.2026 | 14.09.2026 | 21.12.2026 | 05.07.2027 | 05.07.2027 | 07.01.2027 | 18.01.2027 | 18.01.2027 | 23.07.2027 | 29.10.2026 | 11.11.2026 | 23.08.2027 | 01.03.2027 |
| Bid | 39.900 | 98.02 | 100.40 | 88.90 | - | - | 92.10 | 100.20 | - | 100.50 | 96.90 | - | 101.07 | 100.70 | 93.33 | 97.81 | 92.05 | 99.11 | 96.80 | - |
| Ask | - | 98.82 | 101.40 | - | - | - | 93.10 | 102.01 | - | 101.50 | 97.90 | - | 101.88 | 101.70 | 94.13 | 99.60 | - | - | 98.20 | - |